Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Mahmood Shah

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 11, 2012
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Peter A Campochiaro, Syed Mahmood Shah, et al.
Ophthalmology|August 25, 2009
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, David J Browning, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
American Journal of Ophthalmology|June 13, 2024
Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis PigmentosaMichel Michaelides, Cagri G Besirli, Yesa Yang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulatorPeter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, et al.
Ophthalmology|December 30, 2015
Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein OcclusionTahreem A Mir, Saleema Kherani, Gulnar Hafiz, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 11, 2012
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Peter A Campochiaro, Syed Mahmood Shah, et al.
Ophthalmology|August 25, 2009
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, David J Browning, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
American Journal of Ophthalmology|June 13, 2024
Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis PigmentosaMichel Michaelides, Cagri G Besirli, Yesa Yang, et al.
Pageof 4